KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0688 $0.257 Friday, 26th Apr 2024 JAGX stock ended at $0.180. This is 5.88% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 17.29% from a day low at $0.166 to a day high of $0.195.
90 days $0.0519 $0.257
52 weeks $0.0519 $1.22

Historical Jaguar Health, Inc. prices

Date Open High Low Close Volume
Mar 21, 2024 $0.0841 $0.0898 $0.0770 $0.0790 88 456 880
Mar 20, 2024 $0.0990 $0.0999 $0.0731 $0.0799 189 266 361
Mar 19, 2024 $0.0700 $0.0731 $0.0656 $0.0689 20 316 529
Mar 18, 2024 $0.0732 $0.0735 $0.0662 $0.0694 19 960 978
Mar 15, 2024 $0.0705 $0.0808 $0.0700 $0.0700 28 697 870
Mar 14, 2024 $0.0760 $0.0783 $0.0710 $0.0751 27 557 320
Mar 13, 2024 $0.0695 $0.0830 $0.0645 $0.0717 31 848 906
Mar 12, 2024 $0.0720 $0.0750 $0.0660 $0.0683 20 170 099
Mar 11, 2024 $0.0798 $0.0830 $0.0702 $0.0714 23 989 353
Mar 08, 2024 $0.0830 $0.0880 $0.0812 $0.0815 19 516 871
Mar 07, 2024 $0.0884 $0.0896 $0.0734 $0.0817 40 229 516
Mar 06, 2024 $0.109 $0.110 $0.0850 $0.0896 54 589 675
Mar 05, 2024 $0.126 $0.155 $0.115 $0.126 121 414 885
Mar 04, 2024 $0.142 $0.163 $0.116 $0.143 342 272 970
Mar 01, 2024 $0.0609 $0.108 $0.0600 $0.0885 282 986 148
Feb 29, 2024 $0.0591 $0.0630 $0.0581 $0.0590 12 318 080
Feb 28, 2024 $0.0600 $0.0609 $0.0561 $0.0577 19 748 774
Feb 27, 2024 $0.0600 $0.0809 $0.0560 $0.0579 51 514 797
Feb 26, 2024 $0.0614 $0.0660 $0.0591 $0.0600 19 656 918
Feb 23, 2024 $0.0570 $0.0619 $0.0525 $0.0600 24 613 152
Feb 22, 2024 $0.0696 $0.0696 $0.0519 $0.0570 25 164 520
Feb 21, 2024 $0.0696 $0.0709 $0.0662 $0.0673 9 846 185
Feb 20, 2024 $0.0717 $0.0729 $0.0681 $0.0704 20 901 695
Feb 16, 2024 $0.0800 $0.0806 $0.0772 $0.0781 11 828 191
Feb 15, 2024 $0.0870 $0.0873 $0.0790 $0.0820 17 870 012
Click to get the best stock tips daily for free!

About Jaguar Health, Inc.

Jaguar Health. Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer fo... JAGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT